<p><b>Objective:</b> To assess the relationship between the Screen for Cognitive Impairment in Psychiatry (SCIP) score and illness severity, subjective cognition and functioning in a cohort of major depressive disorder (MDD) patients.</p> <p><b>Methods:</b> Patients (<i>n</i> = 40) diagnosed with MDD (DSM-IV-TR) completed the SCIP, a brief neuropsychological test, and a battery of self-administered questionnaires evaluating functioning (GAF, SDS, WHODAS 2.0, EDEC, PDQ-D5). Disease severity was evaluated with the Hamilton Depression Rating Scale (HDRS) and the Clinical Global Impression (CGI).</p> <p><b>Results:</b> Age and sex were associated with performance in the SCIP. The SCIP-Global index score was associated with disease severity (<i>...
Introduction: In this study we estimated the rate and the trajectory of cognitive impairment in a na...
The purpose of this study was to compare the psychometric properties of the Screen for Cognitive Imp...
Objective: Depressive symptoms have a high prevalence in patients with Parkinson's disease (PD) and ...
Background The MATRICS Consensus Cognitive Battery (MCCB) was developed for schizoph...
Background: The Screen for Cognitive Impairment in Psychiatry (SCIP) is a simple and easy to adminis...
Abstract Background Cognitive dysfunction has been reported in acute psychiatric patients for a long...
Aim: The aim of the present study was to investigate the association between cognitive performance a...
Background Psychosocial impairment represents an important treatment target in major depressive diso...
Objective: To evaluate the extent to which cognitive measures in the recently developed THINC-integr...
Background: Major depressive disorder (MDD) is associated with a wide range of cognitive deficits. H...
Introduction: Negative symptoms, neurocognitive deficits and functional impairment are prevalent in ...
At present, there is poor accuracy in assessing cognitive and vegetative symptoms in depression usin...
Purpose: Cognitive impairment is a core feature of major depressive disorder (MDD), and dysfunctions...
Cognitive impairment is emerging as an important therapeutic target in patients with psychiatric ill...
Background: The relevance of persistent cognitive deficits to the pathogenesis and prognosis of bipo...
Introduction: In this study we estimated the rate and the trajectory of cognitive impairment in a na...
The purpose of this study was to compare the psychometric properties of the Screen for Cognitive Imp...
Objective: Depressive symptoms have a high prevalence in patients with Parkinson's disease (PD) and ...
Background The MATRICS Consensus Cognitive Battery (MCCB) was developed for schizoph...
Background: The Screen for Cognitive Impairment in Psychiatry (SCIP) is a simple and easy to adminis...
Abstract Background Cognitive dysfunction has been reported in acute psychiatric patients for a long...
Aim: The aim of the present study was to investigate the association between cognitive performance a...
Background Psychosocial impairment represents an important treatment target in major depressive diso...
Objective: To evaluate the extent to which cognitive measures in the recently developed THINC-integr...
Background: Major depressive disorder (MDD) is associated with a wide range of cognitive deficits. H...
Introduction: Negative symptoms, neurocognitive deficits and functional impairment are prevalent in ...
At present, there is poor accuracy in assessing cognitive and vegetative symptoms in depression usin...
Purpose: Cognitive impairment is a core feature of major depressive disorder (MDD), and dysfunctions...
Cognitive impairment is emerging as an important therapeutic target in patients with psychiatric ill...
Background: The relevance of persistent cognitive deficits to the pathogenesis and prognosis of bipo...
Introduction: In this study we estimated the rate and the trajectory of cognitive impairment in a na...
The purpose of this study was to compare the psychometric properties of the Screen for Cognitive Imp...
Objective: Depressive symptoms have a high prevalence in patients with Parkinson's disease (PD) and ...